Looking for a specific product?

Make a search for products & suppliers, articles & news.

BionorPharma Presentation at DNB Markets Nordic Health Care Conference 27 November 2013

The Company presented update of the clinical development program with three HIV vaccine studies reading out in 2014, and the planned study combining the HIV vaccine Vacc-4x with the reservoir purging agent Romidepsin, so called HDAC inhibitor, aiming towards a functional cure for HIV.

See the presentation here or visit the BionorPharma website here.

Associated companies:

Related news

Latest news

Chairman of IACS pinpoints three key themes of the Association’s strategy for the future

Commenting on the publication of the 2017 Annual Review, 

DNV GL launches alternative fuels white paper

For newbuilding vessels,

MINSHIP Shipmanagement boosts digitalization with DNV GL

MINSHIP is optimizing processes as they are managing a growing fleet. 

The fully electric Future of The Fjords has been launched

The new build is 42m long, 

Winner of Norwegian Export Award 2018 Announced

Airthings is the winner of the Norwegian Export Award 2018. 

Why going in circles is good

In fire detection systems for explosive environments,

Here is AKVA group’s first hybrid feed barge!

Protecting the environment is our main reason to invest in this technology. 

New Display Technologies Enable the Naval Vessel Bridges of the Future

Hatteland Display's cutting-edge display solutions on show at Sea-Air-Space 2018 enable a new data-centric approach to vessel and strategic operations.

Steinsvik Group and Aqualine – collaborating on future solutions

Aqualine is a R&D cage system supplier of cages,